Sunovion (United Kingdom)

Recent papers from Sunovion (United Kingdom)

1. LICET: A Cryptographic Protocol for Multi-Modal Physiological Human-Intent Verification in Autonomous AI Agent Authorization2026
2. An Innovative Treatment Using sterile Hyaluronic Acid Injections to Reduce Foot Ulcer Recurrence in Patients with Diabetes: A Pilot StudyThe International Journal of Lower Extremity Wounds · 2026
3. Traditional Uses, Phytochemicals, and Pharmacological Effects of Cichorium intybus: A Narrative ReviewSudan Journal of Medical Sciences · 2026
4. Scalable fabrication of hypercrosslinked nanobeads for dual photocatalysis: Hydrogen evolution and dye degradationAIChE Journal · 2025
5. Cross-platform motif discovery and benchmarking to explore binding specificities of poorly studied human transcription factorsCommunications Biology · 2025
6. Resolution limit of the eye — how many pixels can we see?Nature Communications · 2025
7. P4HA2 interacted with ATAD3A to modulate PINK1/parkin-dependent mitophagy and 125I brachytherapy sensitization in esophageal carcinomaCell Death and Disease · 2025
8. Technical feasibility of the implementation of an intensive upper-limb rehabilitation system (NeuroVirt) intervention for stroke survivorsBMC Digital Health · 2025
9. From Mining to Manufacturing: Scientific Challenges and Opportunities behind Battery ProductionChemical Reviews · 2025
10. Outpatient subcutaneous alemtuzumab is feasible and safe for aplastic anemia and is associated with high response ratesBlood Advances · 2024
11. Comparison of long-acting injectable antipsychotics with oral antipsychotics and hospital readmission rates in pediatric patientsMental Health Clinician · 2024
12. Lung Structure and Risk of Sleep Apnea in SPIROMICSChronic Obstructive Pulmonary Diseases Journal of the COPD Foundation · 2023
13. A Novel Method for Deriving Adverse Event Prevalence in Randomized Controlled Trials: Potential for Improved Understanding of Benefit-Risk Ratio and Application to Drug LabelsAdvances in Therapy · 2023
14. Interpreting clinical trial outcomes marred by placebo response with an assessment of false-negative and true-negative clinical trials in depression using propensity-weighting2023
15. Exploring real-world symptom impact and improvement in well-being domains for tardive dyskinesia in VMAT2 inhibitor-treated patients via clinician survey and chart reviewMental Health Clinician · 2023
16. Effects of ulotaront on brain circuits of reward, working memory, and emotion processing in healthy volunteers with high or low schizotypySchizophrenia · 2023
17. A First-in-human, Dose-escalation Study of the Methionine Aminopeptidase 2 Inhibitor M8891 in Patients with Advanced Solid TumorsCancer Research Communications · 2023
18. The Effect of Lurasidone on Anxiety Symptoms in Patients With Bipolar DepressionThe Journal of Clinical Psychiatry · 2023
19. Ulotaront: review of preliminary evidence for the efficacy and safety of a TAAR1 agonist in schizophreniaEuropean Archives of Psychiatry and Clinical Neuroscience · 2023
20. A randomized, single‐dose, crossover study of the effects of ulotaront on electrocardiogram intervals in subjects with schizophreniaClinical and Translational Science · 2023